Salt Cedar Allergy Shots: Southwest Summer Aeroallergen SCIT Guide
Salt cedar (Tamarix) allergy shots address a true wind-pollinated Southwest invasive with a uniquely protracted April–September pollen season — the longest of any major US tree allergen. Tamarix gallica extract holds FDA regulatory listing (BLA 101833, first licensed 1968), yet no IUIS allergen exists and no SCIT RCT has been published. Southwest desert residents near riparian corridors should consider Tamarix when summer rhinitis persists beyond typical spring tree season.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Salt Cedar (Tamarisk)is covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Salt Cedar (Tamarisk) Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to salt cedar (tamarisk) — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of salt cedar (tamarisk) allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of salt cedar (tamarisk) immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of salt cedar (tamarisk) extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for salt cedar (tamarisk) allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing salt cedar (tamarisk) extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription salt cedar (tamarisk) immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat salt cedar (tamarisk) allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Salt Cedar (Tamarisk)?
The biology, taxonomy, and clinical fingerprint of Salt Cedar (Tamarisk) — the foundation of how SCIT targets it.
Salt cedar (Tamarix ramosissima) in bloom along a southwestern US riparian corridor, releasing wind-borne pollen from April through September — the longest tree-pollen season of any major US aeroallergen.
- Scientific name
- Tamarix ramosissima (also T. chinensis, T. gallica)
- Family
- TamaricaceaeTamarisk family
- Type
- Invasive shrub/small tree pollen (wind-pollinated)
- Native to
- Central Asia and the Mediterranean; invasive across the American Southwest
- Allergen proteins
- No IUIS-named Tamarix allergen as of May 2026 — molecular allergen catalogue is empty for this genus
- Particle size
- N/A — pollen size not formally characterized in published IgE literature
- Avoidance difficulty
- Very difficult
How Salt Cedar (Tamarisk) Allergy Presents
Symptoms by body system — useful for distinguishing Salt Cedar (Tamarisk) sensitivity from overlapping allergies and infections.
Respiratory
- Sneezing and nasal congestion from April through September along southwestern riparian zones
- Summer rhinitis that persists beyond typical spring tree season and overlaps with monsoon season
- Nasal symptoms worsening near rivers and irrigation canals where Tamarix is densest
- Possible asthmatic exacerbations in sensitized individuals during peak pollen months
- Prolonged exposure window (5+ months) that exhausts seasonal tolerance compared to shorter-season trees
Ocular
- Itchy, watery eyes during the extended spring-through-summer pollen season
- Allergic conjunctivitis that may be attributed to grass or weed pollen rather than Tamarix without specific testing
- Persistent ocular symptoms through the summer months in riparian-corridor communities
Dermal
- No documented OAS food cross-reactivity for Tamarix pollen allergens
- Salt deposits on Tamarix leaves can cause skin irritation on direct contact, distinct from IgE allergy
- Contact dermatitis from the plant is not the primary allergic concern
Systemic
- Fatigue and cognitive burden from five consecutive months of allergic rhinitis
- Sleep disruption extending from April through September in high-exposure desert communities
- Headache and sinus pressure from prolonged seasonal exposure
- Reduced quality of life during the outdoor-recreation season in southwestern desert parks
Salt cedar's April-through-September pollen season is the longest of any major US tree allergen — Southwest patients with summer rhinitis attributed to grass or weed pollen should be tested for Tamarix when riparian exposure is plausible. Missing this diagnosis means five months of preventable symptoms every year.
When & Where Salt Cedar (Tamarisk) Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: May–August along southwestern riparian zones; season extends from April through September· ~6 months — the longest pollen season of any major US tree aeroallergen; overlaps spring tree season, grass season, and ragweed season
US Exposure Map
6 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Moderate
- ID:
- Moderate
- WY:
- Moderate
- SD:
- Low
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- High
- NV:
- High
- UT:
- High
- CO:
- Moderate
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- High
- NM:
- High
- KS:
- Low
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- Low
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Salt Cedar (Tamarisk) Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Salt cedar cross-reactivity is poorly characterized — no formal cross-reactivity study specific to Tamarix has been published, and no OAS food list exists for this allergen.
Is SCIT Right for Your Salt Cedar (Tamarisk) Allergy?
Answer five questions to assess whether salt cedar allergy shots may be appropriate for your summer Southwest rhinitis.
How severe are your summer allergy symptoms from April through September in the Southwest?
The Salt Cedar (Tamarisk) SCIT Protocol
Salt cedar SCIT uses non-standardized aqueous Tamarix extract — FDA-listed but not standardized — typically included in a southwestern X-tree mix alongside mesquite and cottonwood for patients with confirmed summer riparian exposure. Curex IgE testing can identify Tamarix sensitization in Southwest patients whose summer symptoms persist beyond typical spring tree season — the diagnostic foundation before adding salt cedar to a regional immunotherapy mix.
Starting from the most diluted vial (1:100,000 w/v), the allergist incrementally increases the salt-cedar extract concentration. Because salt cedar's pollen season begins in April, fall or early winter build-up initiation allows completing the riskier dose-escalation phase before peak exposure. The 30-minute post-injection observation period is required at every visit.
Ongoing maintenance injections sustain immunologic tolerance during the five-month Southwest pollen season. Because salt cedar overlaps with mesquite and summer grass and ragweed seasons, the full southwest mix must be designed to address all co-occurring sensitizers during the extended exposure window.
After a complete 3–5 year course, lasting benefit extending beyond the active treatment period is expected based on the broader tree-pollen SCIT literature. For patients in high-density Tamarix invasion areas, re-sensitization risk is a consideration if regional Tamarix control programs alter the local pollen load.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Salt Cedar (Tamarisk) SCIT
Salt cedar has no species-specific SCIT RCT and no IUIS-named allergen; the only evidence for clinical inclusion is its documented wind-pollination, regional invasive distribution, and FDA BLA listing — clinical practice extrapolates from the AAAAI Practice Parameter framework for non-characterized tree pollens.
- FDA BLA listing for T. gallica extract (regulatory confirmation of extract viability)50%FDA CBER BLA 101833 — Tamarix gallica non-standardized allergenic extract, first licensed 1968
Salt cedar has no IUIS-named molecular allergen and no published SCIT efficacy RCT as of May 2026. Its clinical relevance rests on documented wind-pollination, one of the longest US tree-pollen seasons (April–September), and an FDA-listed non-standardized extract (BLA 101833). Clinical inclusion in southwestern X-tree mixes follows the AAAAI Practice Parameter framework (Cox et al., JACI 2011) for regionally documented wind-pollinated species. Patients should understand they are accepting empirical, not RCT-proven, evidence when Tamarix is part of their SCIT prescription.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Salt Cedar (Tamarisk) SCIT Side Effects
Salt cedar SCIT follows the standard inhalant immunotherapy safety profile; no Tamarix-specific adverse reaction signal has been reported in the literature beyond class-level SCIT data.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling and redness Standard for tree-pollen SCIT; resolves within 1–2 hours | Rate 30–50% | Mild |
Injection-site pruritus Expected histamine response during dose escalation | Rate 25–40% | Mild |
Large local reaction (>5 cm) Triggers dose adjustment at next visit | Rate 5–10% | Moderate |
Persistent induration Resolves within 24–48 hours | Rate 2–5% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Generalized urticaria or pruritus Requires immediate treatment and dose review | Rate 0.1–0.5% per injection | Moderate |
Rhinitis or conjunctivitis flare Manageable with standard antiallergic medications | Rate 0.1–0.3% per injection | Mild |
Bronchospasm Spirometry monitoring required for comorbid asthma patients | Rate 0.05–0.1% per injection | Moderate |
Anaphylaxis Mandatory 30-minute observation period and epinephrine on hand at all SCIT visits | Rate <0.01% per injection | Severe |
Salt cedar SCIT has traditionally been delivered in a medical facility, but eligible patients can now self-administer the same injections at home through Curex: the serum is sterile-compounded to USP <797>, a prescribed epinephrine auto-injector is confirmed on hand before the first dose, and the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff. A 30-minute self-observation accompanies each dose regardless of prior injection tolerance.
SCIT vs Alternatives for Salt Cedar (Tamarisk)
Southwest patients with summer rhinitis driven by salt cedar exposure have four main options; SCIT is the only disease-modifying option for a five-month annual allergen exposure that cannot be avoided in riparian communities.
| Criterion | SCITBest | SLIT Drops | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (empirical) | Limited (extrapolated) | Minimal (millions of acres invaded) | Symptom control only |
| 5-yr cost | $3,500–$15,000 | $1,500–$4,000 | $0–$300/yr | $200–$1,200/yr |
| Duration | 3–5 years | 3–5 years | Indefinite | Indefinite |
| Convenience | At-home weekly then monthly self-injection with Curex; the first injection from each new vial or concentration supervised live in the Virtual Shot Room | Daily at home | Infeasible in riparian SW | Daily for 5+ months |
| Safety | USP <797> sterile-compounded serum, Virtual Shot Room–supervised dosing, prescribed epinephrine on hand, 30-min self-observation | Self-administered | No medical risk | Generally safe |
| Lasting effect | 7–12 yrs post-course | Ongoing use needed | No lasting change | No lasting change |
SCITBest
SLIT Drops
Avoidance
Medications
For Southwest residents living near Tamarix-invaded riparian corridors, SCIT incorporating salt cedar alongside mesquite and cottonwood offers the only path to lasting symptom modification across the five-month April–September pollen season. Curex IgE testing identifies the full southwestern aeroallergen profile, and eligible patients then self-administer that salt-cedar X-tree shot at home with pricing confirmed in a current program quote — the serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room.
What Salt Cedar (Tamarisk) SCIT Actually Costs
Salt cedar SCIT is billed under standard immunotherapy CPT codes (95115, 95117, 95165) as part of a southwestern X-tree mix. Most major US insurers cover regionally appropriate tree-pollen SCIT when prescribed by a board-certified allergist with documented IgE sensitization. Prior authorization is typically required. The FDA BLA listing for Tamarix gallica extract supports insurance claims for the extract's clinical use.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your salt cedar (tamarisk) allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Salt Cedar (Tamarisk) SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Salt cedar (Tamarix ramosissima and related species) is an invasive shrub or small tree native to central Asia and the Mediterranean that has overrun millions of acres of riparian habitat across the American Southwest — choking the Colorado River, Rio Grande, Pecos River, and hundreds of tributaries in California, Nevada, Arizona, New Mexico, Utah, Texas, and Colorado. Unlike most ornamental plants, salt cedar is wind-pollinated, releasing airborne pollen from small pink flowers through one of the longest seasons of any US tree aeroallergen: April through September. Residents, hikers, and workers near Tamarix-invaded river corridors face up to six months of consecutive allergen exposure each year. The ecological invasion footprint directly scales the allergy burden — the more Tamarix replaces native cottonwood and willow, the higher the regional pollen load.
Salt cedar has the longest pollen season of any major US tree aeroallergen — approximately six months from April through September. By contrast, most spring tree pollens (oak, birch, pecan, sycamore) have windows of 4–8 weeks. Salt cedar's extended season creates a unique clinical challenge: symptoms beginning in spring when other tree pollens are also peaking may seem to resolve with spring trees, then persist through summer — a pattern that should prompt testing for Tamarix. The season can extend further into October in warmer years and at lower elevations, per climate-trend data (Anderegg et al., PNAS 2021). The July–September window overlaps with ragweed season, making differential diagnosis between salt cedar and ragweed a common clinical challenge in the Southwest.
Tamarix gallica extract is FDA-listed as a non-standardized allergenic extract (BLA 101833, first licensed in 1968), giving salt cedar a regulatory footprint among US allergenic products. However, 'non-standardized' means the extract has not been calibrated to a reference standard the way cat hair or short ragweed have been — potency may vary between manufacturers and between batches. No FDA-standardized Tamarix extract and no FDA-approved SLIT tablet for salt cedar exist as of May 2026. Clinical use follows the AAAAI Practice Parameter framework for regionally documented wind-pollinated aeroallergens.
Meaningful avoidance of salt cedar pollen in the Southwest is extremely difficult for residents of invaded regions. Tamarix has displaced native vegetation along hundreds of riparian corridors; in some areas of Arizona, New Mexico, and southern California, it is the dominant riparian plant for miles. HEPA air filtration indoors, keeping windows closed during morning pollen peaks, and avoiding outdoor activity near riverbanks during May–August provide partial reduction in exposure. For desert-Southwest residents whose outdoor recreation, work, or home location places them near riparian corridors, avoidance alone is insufficient, and disease-modifying immunotherapy is a more meaningful long-term strategy.
As of May 2026, no published randomized controlled trial or controlled clinical study specifically evaluating salt cedar SCIT efficacy exists. Salt cedar has no formally named IUIS molecular allergen, which limits the molecular basis for clinical trial design. The FDA BLA 101833 listing for Tamarix gallica extract confirms a regulated extraction process but does not constitute efficacy evidence. Clinical inclusion in southwestern X-tree mixes follows the AAAAI Practice Parameter framework, which supports inclusion of regionally documented wind-pollinated aeroallergens in SCIT prescriptions when IgE sensitization is confirmed. Patients should understand they are accepting empirical, not RCT-validated, evidence when salt cedar is part of their treatment mix.
All three can drive summer rhinitis in the Southwest, but they differ in allergen family, extract characteristics, and treatment options. Salt cedar (Tamarix, Tamaricaceae) pollen season runs April through September; summer grasses (bermuda, johnson) peak May through September; short ragweed peaks August through October. The overlap means a patient with all three sensitizations can have essentially continuous summer symptoms. Key differentiators: grass SCIT uses FDA-standardized bermuda grass extract; ragweed SCIT uses FDA-standardized short ragweed extract — both have more robust evidence bases than salt cedar. A board-certified allergist should test for all three to design the most effective southwestern summer SCIT mix and allocate clinical weight appropriately across the sensitized allergens.
No — salt cedar (Tamarix) is completely unrelated to the 'cedar' trees in Texas (mountain cedar, Juniperus ashei) or the eastern red cedar (Juniperus virginiana). Salt cedar is named for its ability to tolerate saline soil conditions and its feathery cedar-like foliage, not because it is botanically related to Cupressaceae cedar or juniper species. Mountain cedar is in the cypress family (Cupressaceae), contains Jun a 1 pectate lyase as its major allergen, and peaks in December–January in central Texas. Salt cedar is in the Tamaricaceae family, has no formally named allergen, and peaks from April through September in southwestern riparian habitats. Patients with mountain cedar allergy should be specifically tested for Tamarix sensitization separately if they also live near southwestern riparian corridors.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.